Intraneuronal β-amyloid immunoreactivity in the CNS

Neurobiology of Aging

Volumn 17, Issue 2, 1996, Pages 291-299

  Sparks, D Larry ^a,b  

^a UNIVERSITY OF KENTUCKY MEDICAL CENTER   (United States)

^b 203 Sanders Brown Bldg ^*  (United States)

Author keywords

AD like neuropathology in animal models of coronary heart disease; ALZ 50 immunoreactivity; Alzheimer's disease; Coronary heart disease; Down's syndrome; Amyloid accumulation

Indexed keywords

AMYLOID PRECURSOR PROTEIN; CHOLESTEROL;

ADULT; AGED; ALZHEIMER DISEASE; ANIMAL EXPERIMENT; ANIMAL MODEL; ARTICLE; CENTRAL NERVOUS SYSTEM; CONTROLLED STUDY; DIET; DOWN SYNDROME; FEMALE; HIPPOCAMPUS; HUMAN; IMMUNOREACTIVITY; ISCHEMIC HEART DISEASE; MAJOR CLINICAL STUDY; MALE; NEUROPATHOLOGY; NONHUMAN; PRIORITY JOURNAL; RABBIT;

EID: 0029888944     PISSN: 01974580     EISSN: None     Source Type: Journal    
DOI: 10.1016/0197-4580(95)02067-5     Document Type: Article

References (44)

1. Aronson, M. K.; Ooi, W. L.; Morgenstern, H.; Hafner, A.; Masur, D.; Crystal, H.; Frishman, W. H.; Fisher, D.; Katzman, R. Women, myocardial infarction, and dementia in the very old. Neurology 40:1102-1106; 1990.
2. Bouthillier, D.; Sing, C. F.; Davignon, J. Apolipoprotein E phenotyping with a single gel method: Application to the study of informative matings. J. Lipid Res. 24:1060-1069; 1983.
3. Breteler, M. M.; Claus, J. J.; Grobbee, D. E.; Hofman, A. Cardiovascular disease and distribution of cognitive function in elderly people: The Rotterdam study. Br. Med. J. 308:1604-1608; 1994.
4. Burger, P. C.; Vogel, F. S. The development of the pathologic changes of Alzheimer's disease and senile dementia in patients with Down's syndrome. Am. J. Pathol. 73:457-476; 1974.
5. Cordell, B. β-Amyloid formation as a potential therapeutic target for Alzheimer's Disease. Annu. Rev. Pharmacol. Toxicol. 34:69-89; 1994.
6. Cullpepper, W. S., III; Sodt, P. C.; Messerli, F. H. Cardiac status in juvenile borderline hypertension. Ann. Intern. Med. 98:1-7: 1983.
7. Czech, C.; Forstl, H.; Hentschel, F.; Monning, U.; Besthorn, C.; Geiger-Kabisch, C.; Sattel, H.; Masters, C.; Beyreuther, K. Apolipoprotein E-4 gene dose in clinically diagnosed Alzheimer's disease: Prevalence, plasma cholesterol levels and cerebrovascular change. Eur. Arch. Psychiatr. Clin. Neurosci. 243:291-292; 1994.
8. Dickson, D. W.; Lee, S. C.; Mattiace, L. A.; Yen, S. C.; Brosnan, C. Microglia and cytokines in neurological disease, with special reference to AIDS and Alzheimer's disease. Glia 7:75-83; 1993.
9. Frackowiak, J.; Wisniewski, H. M.; Wegiel, J.; Merz, G. S.; Iqbal, K.; Wang, K. C. Ultrastructure of the microglia that phagocytose amyloid and the microglia that produce β-amyloid fibrils. Acta Neuropathol. 84:225-233; 1992.
10. Games, D.; Adams, D.; Alessandrini, R.; Barbour, R.; Berthelette, P.; Blackwell, C.; Carr, T.; Clemens, J.; Donaldson, T.; Gillespie, F., et al. Alzheimer-type neuropathology in transgenic mice overexpressing V717F β-amyloid precursor protein. Nature 373:523-527; 1995.
11. Heston, L. L. Down's syndrome and Alzheimer's dementia. Psychiatr. Dev. 2:287-294; 1984.
12. Higgins, L. S.; Catalano, R.; Quon, D.; Cordell, B. Transgenic mice expressing Human β-App751, but not mice expressing β-APP 695, display early Alzheimer's Disease-like histopathology. Ann. NY Acad. Sci. 695:224-227: 1993.
13. Higgins, L. S.; Holtzman, D. M.; Rabin, J.; Mobley, W. C.; Cordell, B. Transgenic mouse brain histopathology resembles early Alzheimer's Disease. Ann. Neurol. 35:598-607; 1994.
14. Hof, P. R.; Bouras, C.; Mehal, N.; Sparks, D. L.; Perl, D. P.; Morrison, J. H. Age-related distribution of neuropathologic changes in the cerebral cortex of Down Syndrome cases: Quantitative regional analysis and comparison with Alzheimer's disease. Arch. Neurol. 52:379-391; 1995.
15. Hyman, B. T.; Tanzi, R. E.; Marzloff, B. A.; Barbour, R.; Schenk, D. Kunitz protease inhibitor-containing Amyloid β protein precursor immunoreactivity in Alzheimer's disease. J. Neuropathol. Exp. Neurol. 51:76-83; 1992.
16. Inter-Society commission for heart disease resources. Optimal resourses for primary prevention of atherosclerotic disease. Circulation 70:153A-174A; 1984.
17. Kammesheidt, A.; Boyce, F. M.; Spanoyannis, A. F.; Cummings, B. J.; Ortegon, M.; Cotman, C.; Vaught, J. L.; Neve, R. L. Deposition of β/A4 immunoreactivity and neuronal pathology in transgenic mice expressing the carboxyl-terminal fragment of the Alzheimer amyloid precursor in the brain. Proc. Natl. Acad. Sci. USA 89:10857-10861; 1992.
18. Klag, M. J.; Ford, D. E.; Mead, L. A.; He, J.; Whelton, P. K.; Liang, K.-Y.; Levine, D. M. Serum cholesterol in young men and subsequent cardiovascular disease. N. Engl. J. Med. 328:313-318; 1993.
19. Lee, V. M. Y.; Balm, B. J.; Otvos, J., L.; Trojanowski, J. Q. A68: A major subunit of paired helical filaments and derivatized forms of normal tau. Science 251:675-678; 1991.
20. Mahley, R. W. Apolipoprotein E: Cholesterol transport protein with expanded role in cell biology. Science 240:622-630; 1988.
21. Mallat, M.; Houlgatte, R.; Brachet, P.; Prochiantz, A. Lipopolysaccharide-stimulated rat brain macrophages release NGF in vitro. Dev. Biol. 133:309-311; 1989.
22. Mann, D. M. A. The pathologic association between Down syndrome and Alzheimer's disease. Mech. Ageing Dev. 43:99-136; 1988.
23. Mann, D. M. A.; Esiri, M. M. The pattern of acquisition of plaque and tangles in the brain of patients under 50 years of age with Down's syndrome. J. Neurol. Sci. 89:169-179; 1989.
24. Mattiace, L. A.; Davies, P.; Yen, S.-H.; Dickson, D. W. Microglia in cerebellar palques in Alzheimer's disease. Acta Neuropathol. 80:493-498; 1990.
25. Mooradian, A. D.; Lung, C.-C.: Pinnas, J. L. Cholesterol enriched diet enhances malondialdehyde modifgication of proteins in creebral microvessels of rabbits. Neurosci. Lett. 185:211-213; 1995.
26. Prince, M.; Cullen, M.; Mann, A. Risk factor for Alzheimer's disease and dementia: A case-control study based on the MRC elderly hypertension trial. Neurology 44:97-104; 1994.
27. Quon, D.; Wang, Y.; Catalano, R.; Scardina, J. M.; Murakami, K.; Cordell, B. Formation of β-amyloid protein deposits in brains of transgenic mice. Nature 352:239-241; 1991.
28. Roses, A. D. Apolipoprotein E affects the rate of Alzheimer disease expression: β-Amyloid burden is a secondary consequence dependent on APOE genotype and duration of disease. J. Neuropathol. Exp. Neurol. 53:429-437; 1994.
29. Scott, S. A.; Johnson, S. A.; Zarow, C.; Perlmutter, L. S. Inability to detect β-amyloid protein precursor mRNA in Alzheimer plaque-associated microglia. Exp. Neurol. 121:113-118; 1993.
30. Selkoe, D. Physiological production of the β-amyloid protein and the mechanism of Alzheimer's disease. Trends Neurosci. 16:403-409; 1993.
31. Shimijo, M.; Nakajima, K.; Takei, N.; Hamanoue, M.; Kohsaka, S. Production of basic fibroblast growth factor in cultured rat brain microglia. Neurosci. Lett. 123:229-231; 1991.
32. Sing, C. F.; Davignon, J. Role of apolipoprotein E polymorphism in determining normal plasma lipid and lipoprotein variation. Am. J. Hum. Genet. 37:268-285; 1985.
33. Sparks, D. L.; Hunsaker, J. C. Increased ALZ-50-reactive neurons in the brains of SIDS infants: An indicator of greater neuronal death? J. Child. Neurol. 6:123-127; 1991.
34. Sparks, D. L.; Hunsaker, J. C. Down's Syndrome: Occurrence of ALZ-50 reactive neurons and the formation of senile plaques. J. Neurol. Sci. 109:77-82; 1992.
35. Sparks, D. L.; Hunsaker, J. C.; Scheff, S. W.; Kryscio, R. J.; Henson, J. L.; Markesbery, W. R. Cortical senile plaques in coronary artery disease, aging and Alzheimer's disease. Neurobiol. Aging. 11:601-607; 1990.
36. Sparks, D. L.; Liu, H. Laminar and size distribution of senile palques in AD, critical coronary artery disease (cCAD) and normal controls. Soc. Neurosci. Abstr. 22:654; 1992.
37. Sparks, D. L.; Liu, H.; Scheff, S. W.; Coyne, C. M.; Hunsaker, J. C., III. Temporal sequence of plaque formation in the cerebral cortex of nondemented individuals. J. Neuropathol. Exp. Neurol. 52:135-142; 1993.
38. Sparks, D. L.; Scheff, S. W.; Hunsaker, J. C., III; Liu, H.; Landers, T.; Gross, D. R. Induction of Alzheimer-like β-amyloid immunoreactivity in the brains of rabbits with dietary cholesterol. Exp. Neurol. 126:88-94; 1994.
39. Streit, W. J. An improved staining method for rat microglial cells using the lectin from Griffonia simplicifolia (GSA I-B4). J. Histochem. Cytochem. 38:1683-1686; 1990.
40. Streit, W. J.; Kreutzberg, G. W. The response of endogenous glial cells to motor neuron degeneration induced by toxic ricin. J. Comp. Neurol. 268:248-263; 1988.
41. Styren, S. D.; Civin, W. H.; Rogers, J. Molecular, cellular, and pathologic characterization of HLA-DR immunoreactivity in normal elderly and Alzheimer's disease brain. Exp. Neurol. 110:93-104; 1990.
42. Terry, R. D.; Peck, A.; DeTeresa, R.; Schechter, R.; Horoupian, D. S. Some morphometric aspects of the brain in senile dementia of the Alzheimer's type. Ann. Neurol. 10:184-192; 1981.
43. Utermann, G.; Kindermann, I.; Kaffarnik, H.; Steinmetz, A. Apolipoprotein E phenotypes and hyperlipidemia. Hum. Genet. 65:232-236; 1984.
44. Wolozin, B. L.; Pruchnicki, A.; Dickson, D. W.; Davies, P. A neuronal antigen in the brains of Alzheimer's patients. Science 232:648-650; 1986.